CVS Health Co. (NYSE:CVS) Shares Bought by ARGA Investment Management LP

ARGA Investment Management LP lifted its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 7,567.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,402,901 shares of the pharmacy operator's stock after buying an additional 2,371,563 shares during the quarter. CVS Health makes up about 3.5% of ARGA Investment Management LP's holdings, making the stock its 11th biggest holding. ARGA Investment Management LP owned 0.19% of CVS Health worth $107,866,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in CVS. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health during the 3rd quarter valued at $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the 3rd quarter worth about $31,000. Legacy Investment Solutions LLC purchased a new position in CVS Health in the 3rd quarter worth about $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the 3rd quarter valued at about $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health in the third quarter worth approximately $33,000. Institutional investors own 80.66% of the company's stock.

Analyst Ratings Changes

Several brokerages have issued reports on CVS. Barclays dropped their target price on CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research report on Thursday, November 7th. StockNews.com lowered CVS Health from a "hold" rating to a "sell" rating in a report on Thursday, November 14th. UBS Group lifted their price objective on CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a research report on Thursday, November 7th. Evercore ISI raised their target price on shares of CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a research note on Monday, January 27th. Finally, TD Cowen increased their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday, November 25th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat.com, CVS Health presently has an average rating of "Moderate Buy" and a consensus price target of $68.12.

CVS Health Trading Down 1.3 %

Shares of NYSE CVS traded down $0.73 during midday trading on Wednesday, hitting $55.62. The company's stock had a trading volume of 7,640,737 shares, compared to its average volume of 12,688,437. The business's 50 day moving average is $51.11 and its two-hundred day moving average is $56.06. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The firm has a market cap of $69.99 billion, a P/E ratio of 14.12, a price-to-earnings-growth ratio of 0.62 and a beta of 0.61.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business's revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the business posted $2.21 earnings per share. As a group, equities research analysts expect that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.78%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health's dividend payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.